Summary of IDEXX Laboratories (IDXX) 2025 Investor Day Company Overview - IDEXX Laboratories is focused on the pet health care industry, emphasizing innovation and customer-centric solutions to enhance veterinary diagnostics and care [1][2][8][89]. Key Industry Insights - The pet population in the U.S. has increased by 12% from 2020 to 2022, leading to a rise in demand for veterinary services as pets age and require more health care [92][94]. - Average lifespans of pets have increased by nearly two years since 2020, resulting in a 22% increase in diagnostic spending over a pet's lifetime [96]. - There is a significant opportunity in feline health care, as only 30% of cats visited a veterinarian last year compared to 70% of dogs, indicating a need for improved care and diagnostics for cats [97][98]. Core Business Strategies - IDEXX's business model is built on a durable recurring revenue stream, with over 80% of total revenue coming from diagnostics and related services [10][88]. - The company is committed to innovation across various dimensions, including point of care, reference lab services, and customer-facing software [8][21]. - IDEXX aims to increase diagnostics utilization through education and partnerships with veterinary practices, focusing on best practices and standards [15][16][20]. Financial Performance and Growth Opportunities - The company sees a long-term growth opportunity exceeding $45 billion, with a projected growth rate of over 10% [7][86][88]. - IDEXX's investment in R&D is substantial, with a focus on developing integrated solutions that address both clinical and business challenges faced by veterinarians [22][23][24]. Innovations and Product Development - IDEXX has introduced new diagnostic tests, including canine lymphoma and mast cell tumor detection, which are expected to enhance the diagnostic capabilities of veterinary practices [34][39][40]. - The company is expanding its cancer diagnostics panel and aims to include additional tests by 2026, addressing a significant market need [39][42]. Customer Engagement and Software Solutions - IDEXX is developing a vertical SaaS technology stack tailored for animal health, which integrates various applications to optimize veterinary workflows [64][68]. - The company emphasizes the importance of customer relationships and frequent engagement to drive diagnostics usage and improve practice performance [70][72]. Market Trends and Future Outlook - The aging pet population and rising expectations for pet care are expected to drive demand for diagnostics and veterinary services [100][101]. - IDEXX is well-positioned to capitalize on these trends by providing innovative solutions and supporting veterinary practices in meeting the evolving needs of pet owners [86][88]. Conclusion - IDEXX Laboratories is strategically positioned to leverage significant growth opportunities in the pet health care sector through innovation, customer engagement, and a strong focus on diagnostics [88][89].

Company Leadership and Strategy - Burek has been appointed as SVP of Global Quality, focusing on a streamlined global approach to enhance product quality and operational effectiveness [1] - Gadaleta will serve as SVP of Clinical and Regulatory Affairs, leading global clinical trial strategy and regulatory submissions, leveraging his extensive experience in navigating complex global regulations [2] - Sergio's addition to the team is expected to guide innovations through clinical and regulatory pathways, emphasizing the company's commitment to scientific excellence and customer trust [3] Company Overview - QuidelOrtho Corporation is a leader in in vitro diagnostics, developing intelligent solutions that transform data into actionable insights for healthcare [5] - The company specializes in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, providing fast and reliable diagnostics across various settings [5] - QuidelOrtho aims to advance diagnostics by connecting insights and solutions, facilitating informed decision-making in healthcare [6]